NovoSeven - direct healthcare professional communication (DHPC)

eptacog alfa (activated)

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : NovoSeven (eptacog alfa): manufacturing issue leading to supply shortage

Key facts

• Medicine name:
  NovoSeven
• Active substance:
  eptacog alfa (activated)
• Therapeutic area (MeSH):
  • Hemophilia B
  • Thrombasthenia
  • Factor VII Deficiency
  • Hemophilia A
• Procedure number:
  EMEA/H/C/000074
• DHPC type:
  • Medicine shortage
  • Quality defect
• Human ATC codes:
  B02BD08
• Dissemination date:
  19/08/2024